Many people with cdc have no signs or symptoms until the cancer is at an advanced stage.
Collecting duct carcinoma survival rate.
Collecting duct carcinoma cdc is a rare aggressive form of renal carcinoma that presents at an advanced stage and has a poor prognosis.
This aggressive malignancy is considered to be derived from the collecting duct of the kidney and has a poor prognosis in the majority of patients 2 5 with a median survival time of only 22 months following nephrectomy 6.
Little is known concerning the optimal management of cdc.
Collecting duct carcinoma and renal medullary carcinoma are aggressive types of kidney cancer which doctors find challenging to treat.
1 these tumours are found to be locally advanced and with distant metastasis at presentation with 1 to 3 years disease specific survival.
We present the results of a systematic review addressing the management of cdc and the mcmaster university cdc series.
Symptoms may include flank pain unexplained weight loss or blood in the urine.
Histochemical and immunohistochemical studies are often necessary for the diagnosis of collecting duct carcinoma.
Collecting duct carcinomas are rare aggressive malignancies with poor prognosis arising from collecting duct epithelium of the kidney accounting for about 1 3 of all renal cell carcinoma rcc.